Indomethacin

SKU: orb1310593

Description

Indomethacin

Research Area

Cell Biology, Immunology & Inflammation, Metabolism Research, Neuroscience

Key Properties

• CAS Number: 53-86-1
• MW: 357.79
• Purity: 99.84%
• Formula: C₁₉H₁₆ClNO₄
• SMILES: COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
• Target: Autophagy,COX,Phospholipase,PDE
• Solubility: Ethanol:17.9 mg/mL (50.03 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.58 mg/mL (10.01 mM);DMSO:104 mg/mL (290.67 mM)

Bioactivity

• Target IC50:
  COX-1:0.28 μM|COX-2:14 μM
• In Vivo:
  METHODS: To tes the antitumor activity in vivo Indomethacin (1 mg/kg) was administered by gavage to CDF1 mice bearing Colon 26 xenografts twice daily for 7-21 days. Results: Mean tumor weight was significantly lower in bot the long-term and short-term Indomethacin administration groups, serum immunosuppressive acidic protein levels were significantly lower, serum IL-6 levels were also significantly lower, and prostag andin E2 levels in tumor tissues were significantly lower than those in the control group.
• In Vitro:
  METHODS: Human gastric cancer cells AGS were treated with Indomethacin (100-500 µM) for 24 h, an the expression levels of target proteins were detected by Western Blot. Results: Indomethacin increased LC3-II protein levels in AGS cells, which may be a result of induction of autophagy or Inhibition of lysosome-dependent autophagic degradation. METHODS: Human tumor cells HT29 and A431 were treated with Indomethacin (1-10 µM) and EGF (25 ng/mL) for 24-48 h. Cell migration was detected by wound-healing assay. Results: Indomethacin inhibited HT29 cell migration. After treating A431 cells with EGF only the wound closed within 24 h, bu the wound remained open after 24 h of treatment with Indomethacin.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Disclaimer: For research use only

Alternative Names

COX-2, COX-1, COX, Cyclooxygenase, anticancer, anti-infective, Autophagy, Inhibitor, PDE2, inhibit, Indocin, inflammation, Indometacin, Indometacine, Indomethacin, Indomethacine, PLA2

Compound Identifiers

PubChem CID

3715